Apollo Endosurgery Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Apollo Endosurgery are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Apollo Endosurgery has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Apollo Endosurgery is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 91.8 M | |
| Free Cash Flow | -33.5 M |
Apollo |
Apollo Endosurgery Relative Risk vs. Return Landscape
If you would invest (100.00) in Apollo Endosurgery on November 18, 2025 and sell it today you would earn a total of 100.00 from holding Apollo Endosurgery or generate -100.0% return on investment over 90 days. Apollo Endosurgery is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Apollo, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Apollo Endosurgery Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Apollo Endosurgery for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Apollo Endosurgery can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Apollo Endosurgery is not yet fully synchronised with the market data | |
| Apollo Endosurgery has some characteristics of a very speculative penny stock | |
| Apollo Endosurgery has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 76.86 M. Net Loss for the year was (39.84 M) with profit before overhead, payroll, taxes, and interest of 42.43 M. | |
| Apollo Endosurgery currently holds about 74.74 M in cash with (31.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.84. | |
| Roughly 63.0% of the company shares are held by institutions such as insurance companies |
Apollo Endosurgery Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Apollo Stock often depends not only on the future outlook of the current and potential Apollo Endosurgery's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Apollo Endosurgery's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30.2 M | |
| Cash And Short Term Investments | 57 M |
Apollo Endosurgery Fundamentals Growth
Apollo Stock prices reflect investors' perceptions of the future prospects and financial health of Apollo Endosurgery, and Apollo Endosurgery fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Apollo Stock performance.
| Return On Equity | -0.85 | |||
| Return On Asset | -0.14 | |||
| Profit Margin | (0.52) % | |||
| Operating Margin | (0.36) % | |||
| Current Valuation | 400.85 M | |||
| Shares Outstanding | 47.55 M | |||
| Price To Earning | (0.69) X | |||
| Price To Book | 9.78 X | |||
| Price To Sales | 5.78 X | |||
| Revenue | 76.86 M | |||
| EBITDA | (31.62 M) | |||
| Cash And Equivalents | 74.74 M | |||
| Cash Per Share | 1.84 X | |||
| Total Debt | 33.96 M | |||
| Debt To Equity | 1.16 % | |||
| Book Value Per Share | 0.78 X | |||
| Cash Flow From Operations | (31.26 M) | |||
| Earnings Per Share | (1.06) X | |||
| Total Asset | 110.23 M | |||
| Retained Earnings | (256.75 M) | |||
| Current Asset | 9.25 M | |||
| Current Liabilities | 1.08 M | |||
Things to note about Apollo Endosurgery performance evaluation
Checking the ongoing alerts about Apollo Endosurgery for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Apollo Endosurgery help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Apollo Endosurgery is not yet fully synchronised with the market data | |
| Apollo Endosurgery has some characteristics of a very speculative penny stock | |
| Apollo Endosurgery has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 76.86 M. Net Loss for the year was (39.84 M) with profit before overhead, payroll, taxes, and interest of 42.43 M. | |
| Apollo Endosurgery currently holds about 74.74 M in cash with (31.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.84. | |
| Roughly 63.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Apollo Endosurgery's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Apollo Endosurgery's stock is overvalued or undervalued compared to its peers.
- Examining Apollo Endosurgery's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Apollo Endosurgery's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Apollo Endosurgery's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Apollo Endosurgery's stock. These opinions can provide insight into Apollo Endosurgery's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Apollo Stock
If you are still planning to invest in Apollo Endosurgery check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Apollo Endosurgery's history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |